RxDoctor Payments Data

Ann Roberts, MD

Family Medicine · la Grange, KYNPI 1437145695

Payments from drug & device makers

$1,522in general payments, 2019–2025

Across 90 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$304
  • Novo Nordisk$267
  • Amgen$243
  • Takeda Pharmaceuticals U.S.A., Inc.$132
  • Pfizer$124
  • Amarin Pharma, Inc.$114
  • plus $337 from 11 others

What the payments were for

  • Food & beverage$1,522100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,522 in reported general payments places this provider in the 60th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$135,032
Medicare patients
214
Services billed
5,582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin72$85,962
OzempicSemaglutide86$81,798
EliquisApixaban86$75,955
JanuviaSitagliptin Phosphate44$64,409
FarxigaDapagliflozin Propanediol45$59,792
Janumet XrSitagliptin Phos/Metformin Hcl37$53,643
Trelegy ElliptaFluticasone/Umeclidin/Vilanter58$41,996
TrulicityDulaglutide35$37,761
MyrbetriqMirabegron38$29,213
XareltoRivaroxaban25$26,655
LinzessLinaclotide18$22,374
Spiriva RespimatTiotropium Bromide23$14,311
RybelsusSemaglutide14$13,315
Victoza 3-PakLiraglutide11$12,015
Breo ElliptaFluticasone/Vilanterol11$7,994

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet Xr$24$118,05281 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$45$106,328107 claims
Novo NordiskOzempic, Rybelsus$267$95,113100 claims
PfizerEliquis$124$75,95586 claims
AstraZenecaFarxiga, Symbicort$304$66,92663 claims
GSKTrelegy Ellipta, Breo Ellipta$26$49,99069 claims
Astellas Pharma US IncMyrbetriq$34$29,21338 claims
AbbVieLinzess, Synthroid$68$28,962104 claims
Johnson & JohnsonXarelto$29$26,65525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in la Grange

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →